✦ LIBER ✦

Chemotherapy time interval and development of platinum and taxane resistance in ovarian, fallopian, and peritoneal carcinomas

✍ Scribed by Koji Matsuo; Michele L. Eno; Dwight D. Im; Neil B. Rosenshein

Publisher: Springer
Year: 2009
Tongue: English
Weight: 208 KB
Volume: 281
Category: Article
ISSN: 0003-9128
DOI: 10.1007/s00404-009-1121-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low drug resistance to both platinum and

Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer

✍ Koji Matsuo; Virginia K. Bond; Michele L. Eno; Dwight D. Im; Neil B. Rosenshein 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 216 KB 👁 1 views

## Abstract The objective of this study was to evaluate the role of an __in vitro__ drug resistance assay to platinum and taxane in the management of advanced epithelial ovarian, fallopian and primary peritoneal cancer. All patients with FIGO Stage IIIc and IV who received postoperative chemotherap

Usefulness of third-line chemotherapy fo

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy

✍ Shin Nishio; Noriyuki Katsumata; Koji Matsumoto; Hiroshi Tanabe; Kan Yonemori; T 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 264 KB

Combined weekly topotecan and biweekly b

Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer : Results of a Phase 2 Study

✍ Kathryn F. McGonigle; Howard G. Muntz; Jacqueline Vuky; Pamela J. Paley; Dan S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB

Phase 2 study of intraperitoneal topotec

Phase 2 study of intraperitoneal topotecan as consolidation chemotherapy in ovarian and primary peritoneal carcinoma

✍ Howard G. Muntz; Thomas W. Malpass; Kathryn F. McGonigle; Mandy D. Robertson; Pa 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Role of salvage chemotherapy with topote

Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel- and platinum-resistant recurrent ovarian or primary peritoneal cancer: A phase II pilot study

✍ Ghamande, Sharad A.; Piver, M. Steven 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

## Background and Objectives: We assessed the role of salvage chemotherapy with topotecan and cisplatin in patients with platinum-and paclitaxel-resistant advanced and recurrent ovarian or primary peritoneal cancer, based on the reported in vivo and in vitro synergism between these two drugs. Meth

Development of resistance to a trinuclea

Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells

✍ Paola Perego; Laura Gatti; Sabina C. Righetti; Giovanni L. Beretta; Nives Careni 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 295 KB

## Abstract BBR3464 is a trinuclear platinum complex that exhibits a potent cytotoxicity and efficacy against cisplatin‐resistant tumors. To better understand the determinants of cellular resistance to BBR3464, we selected a resistant ovarian carcinoma cell line after exposure to the complex. The r